Recent moves by Schwab, TD Ameritrade and others to eliminate commissions factored into the decision, said LPL's Rob Pettman.
The former congressman on why he backs an ESG index based on LGBTQ values and preferences.
Biotech-focused ETFs dominated the list of the 20 top-performing funds over the past three months.
The Virtus LifeSci Biotech Clinical Trials fund, which trades under the ticker BBC, gained 22%, beating more than 1,970 rivals.
A look at which ETFs and index providers are behind the strong growth in 2019.
ETF assets make up a sliver of these asset managers’ overall business, but their own stock performance bears watching.
The market is a meritocracy, and only the strongest survive.